Stock Rating Downgrade
Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Neogenomics Inc (NASDAQ: NEO) weakened of late. NEO’s current Value Trend Rating is D and the prior Rating was C. Details supporting this lower rating are included in our next report.
Recent Price Action
On 5/20/24, Neogenomics Inc (NASDAQ: NEO) stock rose modestly by 0.7%, closing at $14.91. However, below average trading volume at 77% of normal accompanied the advance. The stock has performed in line with the market over the last nine months and has declined -5.5% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, NEO is expected to continue to be Value Creation neutral.
Neogenomics has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Neogenomics has a poor Appreciation Score of 25 but a neutral Power Rating of 60, resulting in the Negative Value Trend Rating.
Be the first to comment